157 related articles for article (PubMed ID: 7907000)
1. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.
Chuang LT; Lotzová E; Heath J; Cook KR; Munkarah A; Morris M; Wharton JT
Cancer Res; 1994 Mar; 54(5):1286-91. PubMed ID: 7907000
[TBL] [Abstract][Full Text] [Related]
2. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes.
Chuang LT; Lotzová E; Cook KR; Cristoforoni P; Morris M; Wharton JT
Gynecol Oncol; 1993 Jun; 49(3):291-8. PubMed ID: 8100207
[TBL] [Abstract][Full Text] [Related]
3. Effects of taxol and taxol/hyperthermia treatments on the functional polarization of cytotoxic T lymphocytes.
Knox JD; Mitchel RE; Brown DL
Cell Motil Cytoskeleton; 1993; 24(2):129-38. PubMed ID: 8095001
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
Munkarah A; Chuang L; Lotzová E; Cook K; Morris M; Wharton JT
Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
[TBL] [Abstract][Full Text] [Related]
5. Effects of taxol on microtubule organization in mouse splenic lymphocytes and on response to mitogenic stimulation.
Brown DL; Little JE; Chaly N; Schweitzer I; Paulin-Levasseur M
Eur J Cell Biol; 1985 May; 37():130-9. PubMed ID: 2863144
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
[TBL] [Abstract][Full Text] [Related]
8. Microtubules and lymphocyte responses: effect of colchicine and taxol on mitogen-induced human lymphocyte activation and proliferation.
Cuthbert JA; Shay JW
J Cell Physiol; 1983 Aug; 116(2):127-34. PubMed ID: 6134740
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells.
Aoyama M; MacIsaac D; Bukowski RM; Ganapathi MK
Clin Cancer Res; 1998 Apr; 4(4):1039-45. PubMed ID: 9563900
[TBL] [Abstract][Full Text] [Related]
10. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
Zollner TM; Zhu HG; Anderer FA
Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
[TBL] [Abstract][Full Text] [Related]
11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
13. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
Miles EA; Banerjee T; Wells SJ; Calder PC
Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
[TBL] [Abstract][Full Text] [Related]
14. Microtubule assembly after treatment of pig oocytes with taxol: correlation with chromosomes, gamma-tubulin, and MAP kinase.
Sun QY; Lai L; Wu GM; Park KW; Day BN; Prather RS; Schatten H
Mol Reprod Dev; 2001 Dec; 60(4):481-90. PubMed ID: 11746959
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
16. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
17. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
18. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
Rowinsky EK; Donehower RC; Jones RJ; Tucker RW
Cancer Res; 1988 Jul; 48(14):4093-100. PubMed ID: 2898289
[TBL] [Abstract][Full Text] [Related]
19. Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.
Hansson M; Romero A; Thorén F; Hermodsson S; Hellstrand K
J Leukoc Biol; 2004 Dec; 76(6):1207-13. PubMed ID: 15361542
[TBL] [Abstract][Full Text] [Related]
20. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
